Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02129725Phase 4Completed
A Phase 4 trial of sildenafil in metabolic syndrome, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), sponsored by Vanderbilt University Medical Center. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02129725.